Industry Research Reports
Home > Reports > Service & Software > Global Pediatric CAR T-cell Therapy Market Research Report 2024
Global Pediatric CAR T-cell Therapy Market Research Report 2024
Industry: Service & Software
Published Date: 2024-07-26
Pages: 80 Pages
Report ld: 3259063
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Pediatric CAR T-cell Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Pediatric CAR T-cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pediatric CAR T-cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Pediatric CAR T-cell Therapy in Multiple Myeloma is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Pediatric CAR T-cell Therapy include Bristol Myers Squibb，BMS, Johnson & Johnson, Gilead Sciences, Novartis, JW Therapeutics, Imunopharm Technology Co., Ltd., CARsgen Therapeutics, Cartesian Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pediatric CAR T-cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric CAR T-cell Therapy.
The Pediatric CAR T-cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pediatric CAR T-cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric CAR T-cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
By Company
- Bristol Myers Squibb，BMS
- Johnson & Johnson
- Gilead Sciences
- Novartis
- JW Therapeutics
- Imunopharm Technology Co., Ltd.
- CARsgen Therapeutics
- Cartesian Therapeutics
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- CD19
- BCMA
- Others
Segment by Application
- Multiple Myeloma
- B-Cell Lymphoma (BCL)
- Acute Lymphoblastic Leukemia (ALL)
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric CAR T-cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric CAR T-cell Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CD19
1.2.3 BCMA
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pediatric CAR T-cell Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Multiple Myeloma
1.3.3 B-Cell Lymphoma (BCL)
1.3.4 Acute Lymphoblastic Leukemia (ALL)
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric CAR T-cell Therapy Market Perspective (2019-2030)
2.2 Global Pediatric CAR T-cell Therapy Growth Trends by Region
2.2.1 Global Pediatric CAR T-cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pediatric CAR T-cell Therapy Historic Market Size by Region (2019-2024)
2.2.3 Pediatric CAR T-cell Therapy Forecasted Market Size by Region (2025-2030)
2.3 Pediatric CAR T-cell Therapy Market Dynamics
2.3.1 Pediatric CAR T-cell Therapy Industry Trends
2.3.2 Pediatric CAR T-cell Therapy Market Drivers
2.3.3 Pediatric CAR T-cell Therapy Market Challenges
2.3.4 Pediatric CAR T-cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric CAR T-cell Therapy Players by Revenue
3.1.1 Global Top Pediatric CAR T-cell Therapy Players by Revenue (2019-2024)
3.1.2 Global Pediatric CAR T-cell Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Pediatric CAR T-cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pediatric CAR T-cell Therapy Revenue
3.4 Global Pediatric CAR T-cell Therapy Market Concentration Ratio
3.4.1 Global Pediatric CAR T-cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric CAR T-cell Therapy Revenue in 2023
3.5 Global Key Players of Pediatric CAR T-cell Therapy Head office and Area Served
3.6 Global Key Players of Pediatric CAR T-cell Therapy, Product and Application
3.7 Global Key Players of Pediatric CAR T-cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric CAR T-cell Therapy Breakdown Data by Type
4.1 Global Pediatric CAR T-cell Therapy Historic Market Size by Type (2019-2024)
4.2 Global Pediatric CAR T-cell Therapy Forecasted Market Size by Type (2025-2030)
5 Pediatric CAR T-cell Therapy Breakdown Data by Application
5.1 Global Pediatric CAR T-cell Therapy Historic Market Size by Application (2019-2024)
5.2 Global Pediatric CAR T-cell Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pediatric CAR T-cell Therapy Market Size (2019-2030)
6.2 North America Pediatric CAR T-cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pediatric CAR T-cell Therapy Market Size by Country (2019-2024)
6.4 North America Pediatric CAR T-cell Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric CAR T-cell Therapy Market Size (2019-2030)
7.2 Europe Pediatric CAR T-cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pediatric CAR T-cell Therapy Market Size by Country (2019-2024)
7.4 Europe Pediatric CAR T-cell Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric CAR T-cell Therapy Market Size (2019-2030)
8.2 Asia-Pacific Pediatric CAR T-cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pediatric CAR T-cell Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Pediatric CAR T-cell Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric CAR T-cell Therapy Market Size (2019-2030)
9.2 Latin America Pediatric CAR T-cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pediatric CAR T-cell Therapy Market Size by Country (2019-2024)
9.4 Latin America Pediatric CAR T-cell Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric CAR T-cell Therapy Market Size (2019-2030)
10.2 Middle East & Africa Pediatric CAR T-cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol Myers Squibb，BMS
11.1.1 Bristol Myers Squibb，BMS Company Details
11.1.2 Bristol Myers Squibb，BMS Business Overview
11.1.3 Bristol Myers Squibb，BMS Pediatric CAR T-cell Therapy Introduction
11.1.4 Bristol Myers Squibb，BMS Revenue in Pediatric CAR T-cell Therapy Business (2019-2024)
11.1.5 Bristol Myers Squibb，BMS Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Pediatric CAR T-cell Therapy Introduction
11.2.4 Johnson & Johnson Revenue in Pediatric CAR T-cell Therapy Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Pediatric CAR T-cell Therapy Introduction
11.3.4 Gilead Sciences Revenue in Pediatric CAR T-cell Therapy Business (2019-2024)
11.3.5 Gilead Sciences Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Pediatric CAR T-cell Therapy Introduction
11.4.4 Novartis Revenue in Pediatric CAR T-cell Therapy Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Details
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics Pediatric CAR T-cell Therapy Introduction
11.5.4 JW Therapeutics Revenue in Pediatric CAR T-cell Therapy Business (2019-2024)
11.5.5 JW Therapeutics Recent Development
11.6 Imunopharm Technology Co., Ltd.
11.6.1 Imunopharm Technology Co., Ltd. Company Details
11.6.2 Imunopharm Technology Co., Ltd. Business Overview
11.6.3 Imunopharm Technology Co., Ltd. Pediatric CAR T-cell Therapy Introduction
11.6.4 Imunopharm Technology Co., Ltd. Revenue in Pediatric CAR T-cell Therapy Business (2019-2024)
11.6.5 Imunopharm Technology Co., Ltd. Recent Development
11.7 CARsgen Therapeutics
11.7.1 CARsgen Therapeutics Company Details
11.7.2 CARsgen Therapeutics Business Overview
11.7.3 CARsgen Therapeutics Pediatric CAR T-cell Therapy Introduction
11.7.4 CARsgen Therapeutics Revenue in Pediatric CAR T-cell Therapy Business (2019-2024)
11.7.5 CARsgen Therapeutics Recent Development
11.8 Cartesian Therapeutics
11.8.1 Cartesian Therapeutics Company Details
11.8.2 Cartesian Therapeutics Business Overview
11.8.3 Cartesian Therapeutics Pediatric CAR T-cell Therapy Introduction
11.8.4 Cartesian Therapeutics Revenue in Pediatric CAR T-cell Therapy Business (2019-2024)
11.8.5 Cartesian Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Pediatric CAR T-cell Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of CD19
Table 3. Key Players of BCMA
Table 4. Key Players of Others
Table 5. Global Pediatric CAR T-cell Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Pediatric CAR T-cell Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Pediatric CAR T-cell Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Pediatric CAR T-cell Therapy Market Share by Region (2019-2024)
Table 9. Global Pediatric CAR T-cell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Pediatric CAR T-cell Therapy Market Share by Region (2025-2030)
Table 11. Pediatric CAR T-cell Therapy Market Trends
Table 12. Pediatric CAR T-cell Therapy Market Drivers
Table 13. Pediatric CAR T-cell Therapy Market Challenges
Table 14. Pediatric CAR T-cell Therapy Market Restraints
Table 15. Global Pediatric CAR T-cell Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Pediatric CAR T-cell Therapy Market Share by Players (2019-2024)
Table 17. Global Top Pediatric CAR T-cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric CAR T-cell Therapy as of 2023)
Table 18. Ranking of Global Top Pediatric CAR T-cell Therapy Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Pediatric CAR T-cell Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Pediatric CAR T-cell Therapy, Headquarters and Area Served
Table 21. Global Key Players of Pediatric CAR T-cell Therapy, Product and Application
Table 22. Global Key Players of Pediatric CAR T-cell Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pediatric CAR T-cell Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Pediatric CAR T-cell Therapy Revenue Market Share by Type (2019-2024)
Table 26. Global Pediatric CAR T-cell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Pediatric CAR T-cell Therapy Revenue Market Share by Type (2025-2030)
Table 28. Global Pediatric CAR T-cell Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Pediatric CAR T-cell Therapy Revenue Market Share by Application (2019-2024)
Table 30. Global Pediatric CAR T-cell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Pediatric CAR T-cell Therapy Revenue Market Share by Application (2025-2030)
Table 32. North America Pediatric CAR T-cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Pediatric CAR T-cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Pediatric CAR T-cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Pediatric CAR T-cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Pediatric CAR T-cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Pediatric CAR T-cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Pediatric CAR T-cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Pediatric CAR T-cell Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Pediatric CAR T-cell Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Pediatric CAR T-cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Pediatric CAR T-cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Pediatric CAR T-cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Pediatric CAR T-cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Pediatric CAR T-cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 47. Bristol Myers Squibb，BMS Company Details
Table 48. Bristol Myers Squibb，BMS Business Overview
Table 49. Bristol Myers Squibb，BMS Pediatric CAR T-cell Therapy Product
Table 50. Bristol Myers Squibb，BMS Revenue in Pediatric CAR T-cell Therapy Business (2019-2024) & (US$ Million)
Table 51. Bristol Myers Squibb，BMS Recent Development
Table 52. Johnson & Johnson Company Details
Table 53. Johnson & Johnson Business Overview
Table 54. Johnson & Johnson Pediatric CAR T-cell Therapy Product
Table 55. Johnson & Johnson Revenue in Pediatric CAR T-cell Therapy Business (2019-2024) & (US$ Million)
Table 56. Johnson & Johnson Recent Development
Table 57. Gilead Sciences Company Details
Table 58. Gilead Sciences Business Overview
Table 59. Gilead Sciences Pediatric CAR T-cell Therapy Product
Table 60. Gilead Sciences Revenue in Pediatric CAR T-cell Therapy Business (2019-2024) & (US$ Million)
Table 61. Gilead Sciences Recent Development
Table 62. Novartis Company Details
Table 63. Novartis Business Overview
Table 64. Novartis Pediatric CAR T-cell Therapy Product
Table 65. Novartis Revenue in Pediatric CAR T-cell Therapy Business (2019-2024) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. JW Therapeutics Company Details
Table 68. JW Therapeutics Business Overview
Table 69. JW Therapeutics Pediatric CAR T-cell Therapy Product
Table 70. JW Therapeutics Revenue in Pediatric CAR T-cell Therapy Business (2019-2024) & (US$ Million)
Table 71. JW Therapeutics Recent Development
Table 72. Imunopharm Technology Co., Ltd. Company Details
Table 73. Imunopharm Technology Co., Ltd. Business Overview
Table 74. Imunopharm Technology Co., Ltd. Pediatric CAR T-cell Therapy Product
Table 75. Imunopharm Technology Co., Ltd. Revenue in Pediatric CAR T-cell Therapy Business (2019-2024) & (US$ Million)
Table 76. Imunopharm Technology Co., Ltd. Recent Development
Table 77. CARsgen Therapeutics Company Details
Table 78. CARsgen Therapeutics Business Overview
Table 79. CARsgen Therapeutics Pediatric CAR T-cell Therapy Product
Table 80. CARsgen Therapeutics Revenue in Pediatric CAR T-cell Therapy Business (2019-2024) & (US$ Million)
Table 81. CARsgen Therapeutics Recent Development
Table 82. Cartesian Therapeutics Company Details
Table 83. Cartesian Therapeutics Business Overview
Table 84. Cartesian Therapeutics Pediatric CAR T-cell Therapy Product
Table 85. Cartesian Therapeutics Revenue in Pediatric CAR T-cell Therapy Business (2019-2024) & (US$ Million)
Table 86. Cartesian Therapeutics Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
Table 90. Authors List of This Report
List of Figures
Figure 1. Pediatric CAR T-cell Therapy Picture
Figure 2. Global Pediatric CAR T-cell Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pediatric CAR T-cell Therapy Market Share by Type: 2023 VS 2030
Figure 4. CD19 Features
Figure 5. BCMA Features
Figure 6. Others Features
Figure 7. Global Pediatric CAR T-cell Therapy Market Size by Application (2024-2030) & (US$ Million)
Figure 8. Global Pediatric CAR T-cell Therapy Market Share by Application: 2023 VS 2030
Figure 9. Multiple Myeloma Case Studies
Figure 10. B-Cell Lymphoma (BCL) Case Studies
Figure 11. Acute Lymphoblastic Leukemia (ALL) Case Studies
Figure 12. Others Case Studies
Figure 13. Pediatric CAR T-cell Therapy Report Years Considered
Figure 14. Global Pediatric CAR T-cell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Pediatric CAR T-cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Pediatric CAR T-cell Therapy Market Share by Region: 2023 VS 2030
Figure 17. Global Pediatric CAR T-cell Therapy Market Share by Players in 2023
Figure 18. Global Top Pediatric CAR T-cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric CAR T-cell Therapy as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Pediatric CAR T-cell Therapy Revenue in 2023
Figure 20. North America Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Pediatric CAR T-cell Therapy Market Share by Country (2019-2030)
Figure 22. United States Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Pediatric CAR T-cell Therapy Market Share by Country (2019-2030)
Figure 26. Germany Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Pediatric CAR T-cell Therapy Market Share by Region (2019-2030)
Figure 34. China Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Pediatric CAR T-cell Therapy Market Share by Country (2019-2030)
Figure 42. Mexico Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Pediatric CAR T-cell Therapy Market Share by Country (2019-2030)
Figure 46. Turkey Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. UAE Pediatric CAR T-cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Bristol Myers Squibb，BMS Revenue Growth Rate in Pediatric CAR T-cell Therapy Business (2019-2024)
Figure 50. Johnson & Johnson Revenue Growth Rate in Pediatric CAR T-cell Therapy Business (2019-2024)
Figure 51. Gilead Sciences Revenue Growth Rate in Pediatric CAR T-cell Therapy Business (2019-2024)
Figure 52. Novartis Revenue Growth Rate in Pediatric CAR T-cell Therapy Business (2019-2024)
Figure 53. JW Therapeutics Revenue Growth Rate in Pediatric CAR T-cell Therapy Business (2019-2024)
Figure 54. Imunopharm Technology Co., Ltd. Revenue Growth Rate in Pediatric CAR T-cell Therapy Business (2019-2024)
Figure 55. CARsgen Therapeutics Revenue Growth Rate in Pediatric CAR T-cell Therapy Business (2019-2024)
Figure 56. Cartesian Therapeutics Revenue Growth Rate in Pediatric CAR T-cell Therapy Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Pediatric CAR T-cell Therapy market?
The top companies in the global Pediatric CAR T-cell Therapy market are Bristol Myers Squibb，BMS、Johnson & Johnson、Gilead Sciences.
Related Reports
Global Pediatric CAR T-cell Therapy Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Pediatric CAR T-cell Therapy market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 126
USD 4900.00
(Single User License)
Global Pediatric CAR T-cell Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pediatric CAR T-cell Therapy market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 80
USD 4250.00
(Single User License)
Pediatric CAR T-cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pediatric CAR T-cell Therapy was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 91
USD 3950.00
(Single User License)
Global Pediatric CAR T-cell Therapy Market Research Report 2026
The global Pediatric CAR T-cell Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 105
USD 2900.00
(Single User License)
Global Pediatric CAR T-cell Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pediatric CAR T-cell Therapy market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 76
USD 4250.00
(Single User License)
Global Pediatric CAR T-cell Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pediatric CAR T-cell Therapy market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 121
USD 4900.00
(Single User License)
Pediatric CAR T-cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pediatric CAR T-cell Therapy was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 87
USD 3950.00
(Single User License)
Global Pediatric CAR T-cell Therapy Market Research Report 2025
The global market for Pediatric CAR T-cell Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-12
Pages: 79
USD 2900.00
(Single User License)
Global and United States Pediatric CAR T-cell Therapy Market Report & Forecast 2024-2030
The global Pediatric CAR T-cell Therapy revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-07-26
Pages: 94
USD 4350.00
(Single User License)
Global Pediatric CAR T-cell Therapy Market Insights, Forecast to 2030
The global Pediatric CAR T-cell Therapy market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-07-26
Pages: 129
USD 4900.00
(Single User License)
Global Pediatric CAR T-cell Therapy Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Pediatric CAR T-cell Therapy market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 126
USD 4900.00 (Single User License)Global Pediatric CAR T-cell Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pediatric CAR T-cell Therapy market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 80
USD 4250.00 (Single User License)Pediatric CAR T-cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pediatric CAR T-cell Therapy was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 91
USD 3950.00 (Single User License)Global Pediatric CAR T-cell Therapy Market Research Report 2026
The global Pediatric CAR T-cell Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 105
USD 2900.00 (Single User License)Global Pediatric CAR T-cell Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pediatric CAR T-cell Therapy market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 76
USD 4250.00 (Single User License)Global Pediatric CAR T-cell Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pediatric CAR T-cell Therapy market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 121
USD 4900.00 (Single User License)Pediatric CAR T-cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pediatric CAR T-cell Therapy was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 87
USD 3950.00 (Single User License)Global Pediatric CAR T-cell Therapy Market Research Report 2025
The global market for Pediatric CAR T-cell Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-12
Pages: 79
USD 2900.00 (Single User License)Global and United States Pediatric CAR T-cell Therapy Market Report & Forecast 2024-2030
The global Pediatric CAR T-cell Therapy revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-07-26
Pages: 94
USD 4350.00 (Single User License)Global Pediatric CAR T-cell Therapy Market Insights, Forecast to 2030
The global Pediatric CAR T-cell Therapy market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-07-26
Pages: 129
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now